Pasireotide for malignant insulinoma
A phase I clinical trial of dTCApFs, a derivative of a novel human hormone peptide, for the treatment of advanced/metastatic sol
Staphylococcus Coagulase‐Positive Skin Inflammation Associated with Epidermal Growth Factor Receptor‐Targe
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer | NEJM
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Patients with cancer achieve response to messenger RNA COVID-19 vaccine
PDF) Stability and Transitions in Posttraumatic Growth Trajectories Among Cancer Patients: LCA and LTA Analyses | Ruth Pat-Horenczyk, Leia Y Saltzman, Yaira Hamama-raz, Shlomit Perry, and Salomon Stemmer - Academia.edu
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Literature Scan - PORTAL: Program on Regulation, Therapeutics, and Law
Ten-year clinical outcomes in N0 ER+ breast cancer patients with Recurrence Score-guided therapy | npj Breast Cancer
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Durability of response to the third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged 60 years and older: Three-month follo
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
Phase II organâ•'preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to
Salomon STEMMER | Tel Aviv University, Tel Aviv | TAU | Department of Oncology | Scientific profile
